FDA Approves Emergency Use Authorization for Diagnostic Saliva COVID-19 Test Developed by SUNY Upstate Medical University and Quadrant Biosciences
September 25, 2020
September 25, 2020
SYRACUSE, New York, Sept. 25 (TNSRes) -- The State University of New York Upstate Medical University campus issued the following news:
A saliva-based diagnostic test developed by researchers at SUNY Upstate Medical University and Quadrant Biosciences, a Start Up NY company based on the Upstate campus in Syracuse, N.Y., to detect whether an individual is infected with COVID-19 has been granted emergency use authorization by the U.S. Food and Drug Administration.
The anno . . .
A saliva-based diagnostic test developed by researchers at SUNY Upstate Medical University and Quadrant Biosciences, a Start Up NY company based on the Upstate campus in Syracuse, N.Y., to detect whether an individual is infected with COVID-19 has been granted emergency use authorization by the U.S. Food and Drug Administration.
The anno . . .